Elastin peptides induced oxidation of LDL by phagocytic cells

被引:28
作者
Fulop, T
Larbi, A
Fortun, A
Robert, L
Khalil, A
机构
[1] Univ Sherbrooke, Fac Med, Ctr Rech Vieillissement, Sherbrooke, PQ J1H 4C4, Canada
[2] Univ Paris 06, Hotel Dieu, Lab Rech Ophtalmol, Paris, France
来源
PATHOLOGIE BIOLOGIE | 2005年 / 53卷 / 07期
关键词
elastin peptides; monocytes; neutrophils; free radicals; oxLDL; atherosclerosis;
D O I
10.1016/j.patbio.2004.12.023
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The degradation products of one of the major component of vascular wall, elastin, have several important biological activities. Elastin peptides (KE) are mostly generated during vascular aging and the atherosclerotic process. They induce free radical and proteases production from cells, which are the major components of the atherosclerotic process. In the present study, we investigated whether the interaction between elastin peptides and neutrophils as well as monocytes contributes to low density lipoproteins (LDL) oxidation, being one of the most important initiator of the chronic inflammatory process contributing to the development of atherosclerosis. Here, we present data on the link between the elastin degradation products and LDL oxidation by the chemotactically attracted neutrophils and monocytes. The KE as well as the active epitope, the hexapeptide VGVAPG is able, in a differential concentration and time dependence, to induce the oxidation of LDL. KE is able to induce via the production of free radicals by neutrophils the oxidation of LDL very rapidly and in higher concentration compared to monocytes. These effects of KE are occurring through the stimulation of the 67 kDa elastin-laminin receptor (ELR), as demonstrated by the uncoupling effect of lactose. In our present study, the HDL was able to decrease the LDL oxidation by KE. This is a new mechanism by which elastin peptides might participate in the initiation and progression of the atherosclerotic process. (C) 2005 Elsevier SAS. All rights reserved.
引用
收藏
页码:416 / 423
页数:8
相关论文
共 59 条
[1]  
Aikawa M, 2004, CAN J CARDIOL, V20, P631
[2]  
AYCOCK RS, 1986, J BIOL CHEM, V261, P14355
[3]  
BALO J, 1963, REV CONNECT TISSUE R, V68, P241
[4]   Antiinflammatory properties of HDL [J].
Barter, PJ ;
Nicholls, S ;
Rye, KA ;
Anantharamaiah, GM ;
Navab, M ;
Fogelman, AM .
CIRCULATION RESEARCH, 2004, 95 (08) :764-772
[5]  
BIETH J, 1978, FRONTIERS MATRIX BIO, V6, P1
[6]   Lipid retention in the arterial wall of two mouse strains with different atherosclerosis susceptibility [J].
Brown, MD ;
Jin, L ;
Jien, ML ;
Matsumoto, AH ;
Helm, GA ;
Lusis, AJ ;
Frank, JS ;
Shi, WB .
JOURNAL OF LIPID RESEARCH, 2004, 45 (06) :1155-1161
[7]   LIPOPROTEIN METABOLISM IN THE MACROPHAGE - IMPLICATIONS FOR CHOLESTEROL DEPOSITION IN ATHEROSCLEROSIS [J].
BROWN, MS ;
GOLDSTEIN, JL .
ANNUAL REVIEW OF BIOCHEMISTRY, 1983, 52 :223-261
[8]  
Cybulsky MI, 2004, CAN J CARDIOL, V20, p24B
[9]  
DELEENHEER AP, 1978, CLIN CHEM, V24, P585
[10]   Monocytes influence the fate of T cells challenged with oxidised low density lipoproteins towards apoptosis or MHC-restricted proliferation [J].
Fortun, A ;
Khalil, A ;
Gagné, D ;
Douziech, N ;
Kuntz, C ;
Jay-Gerin, JP ;
Dupuis, G ;
Fulop, T .
ATHEROSCLEROSIS, 2001, 156 (01) :11-21